Medical Nutrition

UK site acquisition strengthens KD Pharma’s omega-3 capacity

News in Brief

UK site acquisition strengthens KD Pharma’s omega-3 capacity

By Nathan Gray

Global omega-3 player KD Pharma says the new site at Seal Sands will expand its capacity for manufacturing omega-3-based intermediates, especially for those use in producing active pharmaceutical ingredients (APIs).

Follow us

Featured Events

View more

Products

View more

Webinars